Jill D. Martin

Array ( [id] => 4251533 [patent_doc_number] => 06137029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'PEPCK-insulin gene construct and transgenic mouse' [patent_app_type] => 1 [patent_app_number] => 8/553576 [patent_app_country] => US [patent_app_date] => 1996-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2074 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/137/06137029.pdf [firstpage_image] =>[orig_patent_app_number] => 553576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4205092 [patent_doc_number] => 06027882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Patched genes and their use for diagnostics' [patent_app_type] => 1 [patent_app_number] => 8/656055 [patent_app_country] => US [patent_app_date] => 1996-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22823 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/027/06027882.pdf [firstpage_image] =>[orig_patent_app_number] => 656055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876909 [patent_doc_number] => 05824838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Transgenic mouse model for pituitary disorders associated with LIF overexpression and/or GH underexpression, and its use for testing therapeutic drugs for the conditions' [patent_app_type] => 1 [patent_app_number] => 8/647401 [patent_app_country] => US [patent_app_date] => 1996-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5624 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824838.pdf [firstpage_image] =>[orig_patent_app_number] => 647401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818708 [patent_doc_number] => 05789654 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Transgenic animals deficient in endogenous .beta..sub.3 -adrenergic receptor and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/647118 [patent_app_country] => US [patent_app_date] => 1996-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 10404 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789654.pdf [firstpage_image] =>[orig_patent_app_number] => 647118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089364 [patent_doc_number] => 06025539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'IL-5 transgenic mouse' [patent_app_type] => 1 [patent_app_number] => 8/629643 [patent_app_country] => US [patent_app_date] => 1996-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 16 [patent_no_of_words] => 18003 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025539.pdf [firstpage_image] =>[orig_patent_app_number] => 629643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927282 [patent_doc_number] => 05945576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Mouse model of psoriasis' [patent_app_type] => 1 [patent_app_number] => 8/628761 [patent_app_country] => US [patent_app_date] => 1996-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 15180 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945576.pdf [firstpage_image] =>[orig_patent_app_number] => 628761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3997521 [patent_doc_number] => 05919997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Transgenic mice having modified cell-cycle regulation' [patent_app_type] => 1 [patent_app_number] => 8/627610 [patent_app_country] => US [patent_app_date] => 1996-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 29137 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919997.pdf [firstpage_image] =>[orig_patent_app_number] => 627610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945366 [patent_doc_number] => 05977056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Treatment of thrombotic events' [patent_app_type] => 1 [patent_app_number] => 8/624760 [patent_app_country] => US [patent_app_date] => 1996-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 9732 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977056.pdf [firstpage_image] =>[orig_patent_app_number] => 624760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3853278 [patent_doc_number] => 05767262 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Smooth muscle cell LIM protein' [patent_app_type] => 1 [patent_app_number] => 8/616368 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 14 [patent_no_of_words] => 9352 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767262.pdf [firstpage_image] =>[orig_patent_app_number] => 616368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933539 [patent_doc_number] => 05939400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'DNA vaccination for induction of suppressive T cell response' [patent_app_type] => 1 [patent_app_number] => 8/606639 [patent_app_country] => US [patent_app_date] => 1996-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 8522 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939400.pdf [firstpage_image] =>[orig_patent_app_number] => 606639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834844 [patent_doc_number] => 05744122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Diagnosis and treatment of cancer having clonal macrophage involvement' [patent_app_type] => 1 [patent_app_number] => 8/601865 [patent_app_country] => US [patent_app_date] => 1996-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10428 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744122.pdf [firstpage_image] =>[orig_patent_app_number] => 601865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883876 [patent_doc_number] => 05776772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Method for producing secretable glycosyltransferases and other golgi processing enzymes' [patent_app_type] => 1 [patent_app_number] => 8/593865 [patent_app_country] => US [patent_app_date] => 1996-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8018 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776772.pdf [firstpage_image] =>[orig_patent_app_number] => 593865 [rel_patent_id] =>[rel_patent_doc_number] =>)